Fundraising FoxFluoropharma Medical
Montclair, US · Nevada corporation
Find your way into Fluoropharma Medical
Sign up to see every warm intro you have to Fluoropharma Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fluoropharma Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TR
Tamara RheinExecutive
J(
Johan (Thijs) M. SpoorExecutive
J(
Johan (Thjis) SpoorExecutive
Board
LM
Lawrence M. AtinskyBoard director
AH
Andrew H. SassineBoard director
WW
Walter WitoshkinBoard director
JA
Joseph A. PierroBoard director
PS
Peter S. ContiBoard director
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 4 rounds · 2013–2016
▶$150KraisedApr 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$150KraisedApr 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Walter WitoshkinDirector
- W. Austin LewisDirector
- Thomas H. TulipExecutive Officer, Director
- Peter S. ContiDirector
- Tamara RheinExecutive Officer
- Johan (Thijs) M. SpoorDirector
- Lawrence H. AtinskyDirector
- Offering amount
- $1M
- Amount sold
- $150K
- First sale
- Mar 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$350KraisedJun 2015 · 3 investors · PharmaceuticalsRule 506(b)
▶$350KraisedJun 2015 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Walter WitoshkinDirector
- Lawrence M. AtinskyDirector
- Andrew H. SassineDirector
- Tamara RheinExecutive Officer
- Joseph A. PierroDirector
- Johan (Thijs) M. SpoorExecutive Officer, Director
- Peter S. ContiDirector
- Offering amount
- $2M
- Amount sold
- $350K
- Sales commissions
- $28K
- Placement agents
- Highline Research Advisors LLC
- First sale
- May 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedJul 2014 · 23 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedJul 2014 · 23 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph A. PierroDirector
- Johan (Thijs) M. SpoorExecutive Officer, Director
- Lawrence AtinskyDirector
- Peter S. ContiDirector
- Andrew H. SassineDirector
- Walter WitoshkinDirector
- Tamara RheinExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.2M
- Sales commissions
- $81.6K
- Placement agents
- Monarch Capital Group LLC
- First sale
- Jul 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$877.5KraisedJan 2014 · 16 investors · PharmaceuticalsRule 506(b)
▶$877.5KraisedJan 2014 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Walter WitoshkinDirector
- Tamara RheinExecutive Officer
- Peter S. ContiDirector
- Lawrence AtinskyDirector
- Joseph PierroDirector
- Johan (Thjis) SpoorExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $877.5K
- Sales commissions
- $69.4K
- Placement agents
- Brookline Group LLC
- First sale
- Dec 2013
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Fluoropharma Medical raised?
- Fluoropharma Medical has disclosed $2.6M raised across 4 rounds.
- Where is Fluoropharma Medical headquartered?
- Fluoropharma Medical is headquartered in Montclair, US.